Clinical Trial Update: FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer [NA]

View source ↗

Summary

The document reports the completion of a clinical trial evaluating FLT PET to measure treatment response in newly diagnosed estrogen receptor-positive, HER2-neg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: University of Washington | Conditions: Estrogen Receptor Positive, HER2/Neu Negative | NA | Status: COMPLETED | Results posted: 2017-09-25